Elanco Animal Health Inc's stock surged 9.09% during intraday trading on Wednesday, following the release of its first-quarter financial results and an upward revision to its annual forecast.
The company reported Q1 adjusted earnings per share of $0.40, surpassing the analyst consensus estimate of $0.35, and revenue of $1.37 billion, which also beat expectations of $1.29 billion. This performance represented significant growth, with revenue climbing 15% year-over-year.
Driving the positive sentiment, Elanco raised its full-year 2026 revenue guidance to a range of $5.01 billion to $5.09 billion, up from its previous forecast, and lifted its adjusted EPS outlook to $1.03-$1.09. The strong quarterly results and optimistic updated guidance fueled investor confidence, leading to the substantial share price increase.
Comments